The £50m partnership between Cancer Research UK, University of Manchester, University College London, Knight Cancer Institute at OHSU and University of Cambridge will be joined by the Dana-Farber Cancer Institute and the German Cancer Research Centre as the Alliance expands in the USA and Europe. Read More
On Monday 7th October 2024, we were delighted to host the Cancer Research UK (CRUK) Manchester Centre Celebration at the OCRB, to celebrate its halfway milestone under the theme: Precision Medicine for All – The Science Behind the Centre. This blog summarises what we covered throughout the day. Read More
The National Biomarker Centre is led by Professor Caroline Dive and funded through a £2.5m investment from CRUK. Read More
Read about the MCRC Springboard Awards which support early-stage innovations showing the greatest potential to deliver patient impact with a pump prime funding programme. Read More
Part of a larger £58m investment from Cancer Research UK Read More
A simple, safe and accurate test that identifies women with womb cancer from a sample taken from the vagina has been developed by clinician scientists from The University of Manchester. Read More
Recognising her engagement work with local students from working class backgrounds and approach to sustainability, peer support and teaching inside and outside the laboratory. Read More
Over the next two months, Macarena, Nadin and Hadiyat will return to their medical studies while also writing up their theses aiming to graduate with MBChB and PhD in 2025 or 2026. Read More
Following a devastating fire which caused significant damage to the Paterson cancer research facility in 2017, building work on the new Paterson building at The Christie NHS Foundation Trust in Manchester has completed. Read More
On Saturday 1st October, the MCRC had the pleasure of welcoming four schools from across the Greater Manchester area to a ‘taster day’, designed to bridge the gap between A-level studies and science as a career researcher. Read More
The major funding investment of more than £3m aims to provide future hope for people diagnosed with the disease. Read More
